Back to Trades
Total Value
$2.0M
Net $2.0M sold
Filing Date
Jul 9, 2026
4 transactions
Sales
$2.0M
4 transactions
Trade Summary
On Jul 7, 2026, Fordyce Marshall, Insider, sold $2.0M of Vera Therapeutics, Inc. (VERA) across 4 transactions. The filing covers Class A Common Stock and reflects net selling of $2.0M. Reported prices ranged from $40.78 to $43.59. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Vera Therapeutics, Inc.
- Ticker Symbol
- VERA
- CIK
- 0001831828
Insider Information
- Name
- Fordyce Marshall
- Role
- Insider
- Location
- BRISBANE, CA
Filing Details
- Filing Date
- Jul 9, 2026
- Transaction Date
- Jul 7, 2026
- Accession Number
- 0001859453-26-000010
- Form Type
- 4
- Net Trading Amount
- -$2.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Class A Common Stock | 1,000 | $40.78 | Sale | $40.8K |
| Jul 7, 2026 | Class A Common Stock | 32,550 | $42.07 | Sale | $1.4M |
| Jul 7, 2026 | Class A Common Stock | 10,500 | $42.86 | Sale | $450.0K |
| Jul 7, 2026 | Class A Common Stock | 2,200 | $43.59 | Sale | $95.9K |
Want live alerts when Fordyce Marshall trades again?
Download Insider Trades to track VERA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
- (F2)The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.39 to $41.31, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- (F3)The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.39, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- (F4)The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.40 to $43.38, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- (F5)The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.42 to $43.97, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.